1-1 of 1
on Behalf of ECO-1 Study Investigators
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Early Estimates of Safety for Alemtuzumab Combined with Fludarabine for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia: Phase II Multicenter Study.

Jennifer R. Brown, MD, Wendy Stock, MD, Harvey I. Katzen, MD, Agustin J. Suarez, MD, Shailendra Lakhanpal, Jose F. Leis, MD, Christopher Flowers, MD, on Behalf of ECO-1 Study Investigators
Journal: Blood
Blood (2006) 108 (11): 4989.
https://doi.org/10.1182/blood.V108.11.4989.4989
Published: 2006